Craft Botanicals International

Licensed Canadian Processing Platform

Processing Infrastructure for Regulated Medical Cannabis Markets

Craft Botanicals International is a Calgary-based processing company with licensed Canadian infrastructure, pharmaceutical-grade operating standards, and a platform designed for compliant domestic and international medical channels.

Health Canada Licensed Calgary Processing Hub EU-GMP Readiness Pathway

Infrastructure, compliance, and commercial readiness.

01

Licensed Processing Base

Health Canada licensed processing infrastructure with pharmaceutical-grade operating discipline.

02

Execution-Ready Facility

Calgary hub with physical upgrades completed and a pathway aligned with EU-GMP activation.

03

International Orientation

Domestic operations supported by an export-facing model built for regulated medical markets.

Platform Thesis

Built as an Operating Platform

Craft Botanicals International is not positioned as a cultivation-heavy story. The company is built around compliant sourcing, controlled processing, quality systems, and access to regulated medical channels.

01

Source

Compliant upstream inputs sourced through an asset-light model.

02

Process

Processing, formulation, and quality systems designed for regulated channels.

03

Export

Commercial pathways spanning Canada and international medical markets.

Market Opportunity

The Constraint Is Certification, Not Supply

Global medical markets are standardizing around EU-GMP compliant supply chains while certified processing capacity remains limited. Craft Botanicals is positioned around the compliance bottleneck that separates input availability from premium medical market access.

Canadian compliant inputs

GACP Flower Supply

Large-volume compliant biomass available within the Canadian licensed ecosystem.

EU-GMP Certification Bottleneck
Premium international channels

Premium Output

Pharmaceutical-grade product positioned for Europe, Australia, and other regulated medical markets.

The key commercial friction is certification capacity, not raw input availability.

Operating Model

A Clear, Disciplined Commercial Approach

01

Source

Source compliant biomass through an asset-light model without cultivation-heavy complexity.

02

Process

Process through owned infrastructure using quality systems suited to regulated medical channels.

03

Export

Serve Canadian channels while building toward international regulated market access.

Revenue Engine

Multiple Revenue Paths from One Infrastructure Base

The platform is designed to support branded domestic activity, processing services, and international commercial expansion from a single operating core.

Canadian Branded Portfolio

Canadian product activity supported by established distribution relationships.

Processing Services

Fee-based processing capabilities structured around compliant third-party inputs.

International Markets

Longer-term expansion through regulated medical export markets including Europe and Australia.

Balanced model: domestic activity, service revenue, and international expansion from the same infrastructure base.

Infrastructure

Built for Execution

Craft Botanicals has operating infrastructure in place, physical upgrades completed, and a platform designed to support disciplined commercial growth.

  • Calgary processing hub
  • Health Canada licensed micro-processing platform
  • Pharmaceutical-grade operating orientation
  • EU-GMP readiness pathway supported by completed physical upgrades
Infrastructure

Licensed platform with core upgrades completed

Compliance

Quality and regulatory systems aligned to medical market requirements

Commercial

Domestic and international commercial pathways in development

Set the Home page featured image to replace this panel.

Innovation Platform

Product and IP Development on Top of the Core Platform

In addition to core processing infrastructure, Craft Botanicals is building product, formulation, and regulatory capabilities intended to support long-term differentiation.

ST

StickIt Technology

Delivery platform

  • Patented delivery technology in Canada and Australia
  • Continuous research into novel applications
  • Dosage innovation platform with potential differentiated product pathways
SF

StripIt Formulations

Thin-film formulation platform

  • Development of advanced thin-film pharmaceutical delivery systems
  • High-precision dosing platform with scalable formulation applications
RI

Regulatory Intelligence Infrastructure

Compliance systems layer

  • AI-driven regulatory automation infrastructure under ongoing development
  • Designed to adapt to evolving standards for stronger compliance efficiency and scalability

Global Reach

Canadian Infrastructure with International Relevance

A centralized Calgary processing hub with commercial orientation toward Canada, Europe, Australia, and other regulated medical markets.

Calgary Centralized processing hub
Europe Representative regulated medical market point
Australia Representative regulated medical market point

Leadership

Leadership with Regulatory, Commercial, and Capital Markets Experience

Leadership spanning public markets, regulatory systems, quality infrastructure, and international commercialization.

Shawn Ripley

Shawn Ripley

Chief Executive Officer

Regulatory Infrastructure & Commercialization

Regulatory infrastructure and commercialization executive with experience in Health Canada licensing, quality systems, and EU-GMP readiness pathways.

Cameron Battley

Cameron Battley

Strategic Advisor

Global Regulatory & Capital Markets

Global regulatory and capital markets executive with experience across major cannabis operators including Aurora, Canopy Growth, and MedReleaf Australia.

Contact

Start the Right Conversation

For processing, strategic partnerships, international market discussions, or investor materials.

Calgary, Alberta

info@ripco.pro

Get in Touch

Tell us what you are exploring and we will route the inquiry to the right conversation or materials request.

View Our Platform

Prefer email?

info@ripco.pro